Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Bargiel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 25, 2021
The proliferation of belatacept-resistant T cells requires early IFNα pathway activationFlorence Herr, Christophe Desterke, Karen Bargiel, et al.
Frontiers in Immunology|April 10, 2026
The inhibitory receptor NKG2A is expressed on T-cells during BKPyVANephropathyKaren Bargiel, Christophe Desterke, Manon Dekeyser, et al.
Pharmaceutics|April 28, 2023
mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4<sup>+</sup>CD57<sup>+</sup> T Cells In Vivo and In VitroFlorence Herr, Manon Dekeyser, Jerome Le Pavec, et al.
Transplantation|June 17, 2025
BKPyV-specific T-cell Exhaustion in Kidney Transplant Recipients: Targeting Inhibitory Receptors Improves Their FunctionalityKaren Bargiel, Ivan Scriabine, Florence Herr, et al.
Kidney International Reports|August 19, 2024
Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant RecipientsManon Dekeyser, Marie-Ghislaine de Goër de Herve, Houria Hendel-Chavez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 25, 2021
The proliferation of belatacept-resistant T cells requires early IFNα pathway activationFlorence Herr, Christophe Desterke, Karen Bargiel, et al.
Frontiers in Immunology|April 10, 2026
The inhibitory receptor NKG2A is expressed on T-cells during BKPyVANephropathyKaren Bargiel, Christophe Desterke, Manon Dekeyser, et al.
Pharmaceutics|April 28, 2023
mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4<sup>+</sup>CD57<sup>+</sup> T Cells In Vivo and In VitroFlorence Herr, Manon Dekeyser, Jerome Le Pavec, et al.
Transplantation|June 17, 2025
BKPyV-specific T-cell Exhaustion in Kidney Transplant Recipients: Targeting Inhibitory Receptors Improves Their FunctionalityKaren Bargiel, Ivan Scriabine, Florence Herr, et al.
Kidney International Reports|August 19, 2024
Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant RecipientsManon Dekeyser, Marie-Ghislaine de Goër de Herve, Houria Hendel-Chavez, et al.
Pageof 1